- 专利标题: Compounds targeting PRMT5
-
申请号: US16836132申请日: 2020-03-31
-
公开(公告)号: US11198699B2公开(公告)日: 2021-12-14
- 发明人: Koen Vandyck , Pierre Jean-Marie Bernard Raboisson , Jerome Deval , Leonid Beigelman , David McGowan , Yannick Debing
- 申请人: ALIGOS THERAPEUTICS, INC.
- 申请人地址: US CA South San Francisco
- 专利权人: ALIGOS THERAPEUTICS, INC.
- 当前专利权人: ALIGOS THERAPEUTICS, INC.
- 当前专利权人地址: US CA South San Francisco
- 代理机构: Knobbe Martens Olson & Bear LLP
- 主分类号: C07D495/04
- IPC分类号: C07D495/04 ; C07D513/04 ; C07D519/00 ; C07D487/04 ; C07D473/34 ; A61K31/53 ; A61K31/52 ; A61K31/519 ; A61K31/522 ; C07D473/30 ; A61K31/437 ; A61P35/00 ; C07D473/26 ; C07D471/04 ; C07K16/22
摘要:
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
公开/授权文献
- US20200317686A1 COMPOUNDS TARGETING PRMT5 公开/授权日:2020-10-08
信息查询